Bastion Therapeutics

Bastion Therapeutics

Biotechnology Research

Creating a future where inflammatory disorders are curable

About us

Bastion Therapeutics is a preclinical stage biotech with a mission to develop novel Treg cell therapies to address the unmet clinical need for inflammatory disorders. We leverage our proprietary GRIT™ platform technology to engineer Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg cell therapies. Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
London
Type
Privately Held

Locations

Employees at Bastion Therapeutics

Updates

Similar pages

Funding